Your browser doesn't support javascript.
loading
Optimization of a biotechnological multiproduct batch plant design for the manufacture of four different products: A real case scenario.
Sandoval, Gabriela; Espinoza, Daniel; Figueroa, Nicolas; Asenjo, Juan A.
Afiliación
  • Sandoval G; Centre of Biotechnology and Bioengineering, CeBiB, Department of Chemical Engineering and Biotechnology, University of Chile, Beauchef 851, Santiago 8370456, Chile.
  • Espinoza D; Facultad de Ingeniería y Tecnologí-a, Universidad de San Sebastián, Bellavista 7, Santiago 8420524, Chile.
  • Figueroa N; Facultad de Ciencias Fí-sicas y Matemáticas, Departamento de Ingenierí-a Industrial, Universidad de Chile, Santiago, Chile.
  • Asenjo JA; Instituto de Economí-a, Pontificia Universidad Católica de Chile, Santiago, Chile.
Biotechnol Bioeng ; 114(6): 1252-1263, 2017 06.
Article en En | MEDLINE | ID: mdl-28145566
In this work a biotechnological multiproduct batch plant that manufactures four different recombinant proteins for human application is described in some detail. This batch plant design is then optimized with regards to the size of equipment using a mixed-integer linear programming (MILP) formulation recently developed by us in order to find a hypothetical new biotechnological batch plant based on the information of real known processes for the production of the four recombinant protein products. The real plant was divided for practical purposes into two sub-processes or facilities: a fermentation facility and a purification facility. Knowing the specific steps conforming the downstream processing of each product, size, and time factors were computed and used as parameters to solve the aforementioned MILP reformulation. New constraints were included to permit the selection of some equipment-such as centrifuges and membrane filters-in a discrete set of sizes. For equipment that can be built according to customer needs-such as reactors-the original formulation was retained. Computational results show the ability of this optimization methodology to deal with real data giving reliable solutions for a multi-product batch plant composed of 44 unit operations in a relatively small amount of time showing that in the case studied it is possible to save up to a 66% of the capital investment in equipment given the cost data used. Biotechnol. Bioeng. 2017;114: 1252-1263. © 2017 Wiley Periodicals, Inc.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes / Ingeniería de Proteínas / Reactores Biológicos / Técnicas de Cultivo Celular por Lotes Tipo de estudio: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Biotechnol Bioeng Año: 2017 Tipo del documento: Article País de afiliación: Chile

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes / Ingeniería de Proteínas / Reactores Biológicos / Técnicas de Cultivo Celular por Lotes Tipo de estudio: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: Biotechnol Bioeng Año: 2017 Tipo del documento: Article País de afiliación: Chile